HiPerGator supercomputer accelerates diabetes drug discovery

Working with medicinal chemist Theodore Kamenecka, Ph.D., UF Scripps Scientific Director Patrick Griffin, Ph.D., has designed potential medications for type 2 diabetes that increase cells’ sensitivity to insulin while limiting side-effects of older medications.